Tolnaftate is NOT Effective for Onychomycosis
Tolnaftate should not be used for onychomycosis in any formulation—neither cream nor solution—as it is explicitly ineffective for nail infections. The FDA drug label clearly states that tolnaftate "is not effective on the scalp or nails" 1. This is a critical distinction that supersedes any comparison between formulations.
Why This Matters
The British Association of Dermatologists' 2014 guidelines make no mention of tolnaftate as a treatment option for onychomycosis, instead recommending:
First-line systemic therapy:
- Terbinafine 250 mg daily (6 weeks for fingernails, 12-16 weeks for toenails) - Strength of recommendation A 2
- Itraconazole (pulse or continuous therapy) - Strength of recommendation A 2
Topical therapy options (for limited disease only):
- Amorolfine 5% lacquer - ~50% efficacy in distal onychomycosis 2
- Ciclopirox 8% lacquer - 34% mycological cure vs 10% placebo 2
- Tioconazole 28% solution - 22% cure rate 2
The Evidence Against Tolnaftate
While one older study from 1983 combined 2% tolnaftate ointment with 20% urea under occlusive dressing 3, this approach:
- Required aggressive nail removal techniques
- Showed only 70% response rate (14/20 patients)
- Is not standard practice and not recommended in current guidelines
- The urea component (for nail debridement) likely contributed more than the tolnaftate
A 2020 comparative study found tolnaftate solution inferior to clotrimazole for otomycosis (ear fungal infections), with only 45% resolution vs 75% with clotrimazole, plus higher recurrence rates 4. This further demonstrates tolnaftate's limited antifungal efficacy.
What You Should Actually Use
For moderate-to-severe onychomycosis:
- Oral terbinafine is superior to itraconazole with 46% vs 13% long-term mycological cure at 5 years 2
- Combination therapy (oral + topical) is recommended when response to monotherapy is likely poor 2
For mild disease (<80% nail involvement, no lunula involvement):
- Amorolfine 5% lacquer once-twice weekly for 6-12 months 2
- Efinaconazole 10% solution (newer agent with ~50% mycological cure) 2
Common Pitfall
Do not confuse tolnaftate's effectiveness for superficial dermatophyte infections (athlete's foot, ringworm, jock itch) with nail infections. The nail plate's hard keratin structure prevents adequate drug penetration 2, and tolnaftate lacks sufficient potency even if it could penetrate effectively.
Bottom line: Neither tolnaftate cream nor solution should be used for onychomycosis. Choose evidence-based therapies with proven efficacy for nail infections.